Journal of Research in Applied and Basic Medical Sciences

en Complaisance of COVID-19 vaccination in cancer patients: A North Indian Tertiary Cancer Center (TCC) annotation Radiotherapy Radiotherapy پژوهشي orginal article Background & Aims:  Because of waxing and waning nature of Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it has turned the entire globe upside down since its conception in December 2019. Vaccination against COVID-19 has emerged as the only ray of light in this dark tunnel of the pandemic, and has proven to curtail the morbidity and mortality associated with the viral infection. Thus, aspiration behind doing this study was to present the actual conformity of Indian cancer center patient population to COVID-19 vaccination. Materials & Methods: The current prospective research was conducted on 396 cancer patients from North Indian Tertiary Cancer Center (TCC) between October 2021-February 2022 to analyze vaccine acceptance among its cancer patients. Face-to-face interviews were done to ask about the demographics and status of vaccination. Data was analyzed using SPSS v.25. Quantitative data presented as mean and standard deviation (SD). Qualitative data presented as ratios and percentages. Qualitative data were compared using Chi-square test. p<0.05 was considered significant. Results: Among 396 patients, 221 (55.80%) were male and 175 (44.19%) were female, and mean age of study population was 55.96 years. 292 (73.74%) were from rural background while 104 (26.26%) belonged to urban background. Most common site of malignancy was head and neck cancer with 40.66% patients. 245 (61.36%) out of 396 patients were vaccinated either with single or both doses of COVID-19 vaccine, but 153 (38.64%) were not vaccinated. Out of vaccinated patients, 70.37% patients were fully vaccinated with 2 doses and 29.63% were vaccinated with single dose of COVID-19 vaccination. Conclusion: Hesitancy of cancer patients in receiving COVID-19 vaccination is still a big hurdle to return to pre-pandemic oncological care, and this can be mitigated by amalgamated active efforts of government, treating oncologist and family of cancer patients. Cancer, COVID-19 Infection, COVID-19 Vaccine, Vaccine Acceptance 200 209 http://ijrabms.umsu.ac.ir/browse.php?a_code=A-10-304-1&slc_lang=en&sid=1 Shailley Arora Sehgal drshailley@gmail.com 10031947532846002243 10031947532846002243 Yes Assistant Professor, Department of Radiation Oncology, Regional Cancer Center, Pt B D Sharma PGIMS, Rohtak (Haryana), India Garima Malik drgarima2005@gmail.com 10031947532846002244 10031947532846002244 No Assistant Professor, Department of Radiation Oncology, Regional Cancer Center, Pt B D Sharma PGIMS, Rohtak (Haryana), India (Corresponding Author) Rajeev Atri rajeevatri@gmail.com 10031947532846002245 0009-0003-4036-4773 No Professor, Department of Radiation Oncology, Regional Cancer Center, Pt B D Sharma PGIMS, Rohtak (Haryana), India Paramjeet Kaur drparamjitkaur@rediffmail.com 10031947532846002246 0002-0002-0083-9450 No Professor, Department of Radiation Oncology, Regional Cancer Center, Pt B D Sharma PGIMS, Rohtak (Haryana), India Rakesh Malik docgarimarakeshmalik@gmail.com 10031947532846002247 0009-0003-6141-9278 No MBBS, PG (Post Graduate) Final Year, Anesthesia, Apollo Hospitals, Bannerghatta, Bengaluru, Karnataka, India Sachin Sehgal mail2sachin81@gmail.com 10031947532846002248 0009-0009-1502-0139 No Department of Ophthalmology, Civil Hospital, Rohtak, Haryana, India Vivek Kaushal vkkaushal@gmail.com 10031947532846002249 10031947532846002249 No Senior Professor and Unit II Head, Department of Radiation Oncology, Regional Cancer Center, Pt B D Sharma PGIMS, Rohtak (Haryana), India Ashok Chauhan drchauhanashok@yahoo.co.in 10031947532846002250 10031947532846002250 No Senior Professor and Head, Department of Radiation Oncology, Regional Cancer Center, Pt B D Sharma PGIMS, Rohtak (Haryana), India